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Gender Differences in Diagnostic Values of Visceral Fat Area  
and Waist Circumference for Predicting Metabolic Syndrome  
in Koreans 
Abdominal fat accumulation is known to be strongly implicated in development of 
metabolic syndrome (MetS). We examined diagnostic values of obesity-related parameters 
in 95 men and 185 women, and we determined optimal cutoff values of visceral fat area 
(VFA) and waist circumference (WC) for predicting the presence of multiple non-adipose 
components of MetS. Receiver operating characteristic (ROC) curve analysis revealed that 
VFA was the best indicator of MetS. WC and VFA exhibited similar diagnostic values for 
men and postmenopausal women, whereas WC was inferior to VFA for premenopausal 
women (area under ROC curve of VFA and WC was 0.76 and 0.52, respectively; P < 0.001). 
Optimal cutoff points of VFA and WC for predicting MetS were 136 cm
2 and 89 cm in men 
and 95 cm
2 and 82 cm in women, respectively. Subjects with VFA and WC above these 
cutoff values exhibited increased insulin resistance and increased carotid intima-media 
thickness. In conclusion, WC has a diagnostic value similar to VFA for predicting MetS in 
men and postmenopausal women, but not in premenopausal women. Further studies are 
necessary to develop a simple clinical parameter that reflects visceral fat in premenopausal 
women.
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INTRODUCTION
Metabolic syndrome (MetS) is an important public health prob-
lem and it increases the risk of type 2 diabetes and cardiovascu-
lar disease (1). Although the pathogenesis of MetS has yet to be 
determined, it is evident that the abdominal fat accumulation 
plays a central role (2). Compared to the subcutaneous abdom-
inal fat, the visceral abdominal fat confers more of a risk of met-
abolic and cardiovascular complications. This notion may be 
explained by the fact that the visceral fat has a higher lipolytic 
activity and it directly releases free fatty acids into the portal cir-
culation, and this considerably contributes to insulin resistance 
(3). In addition, abdominal obesity has been strongly implicated 
in the development of MetS as well as increased all-cause and 
cardiovascular mortality (3, 4). 
  The International Diabetes Federation (IDF) includes abdom-
inal obesity as an essential element of MetS and the IDF has de-
fined the waist circumference (WC) cutoff values according to 
ethnicity and gender (e.g., the WC values of 90 cm for men and 
80 cm for women in South Asia and China) (5). Compared to 
Caucasians, Asians typically exhibit a higher risk of obesity-re-
lated morbidity and mortality at a given body mass index (BMI) 
or WC (6). Furthermore, in the Obesity in Asia Collaboration, 
which evaluated the optimal WC cutoff values for the identifi-
cation of diabetes in 155,122 individuals from 10 countries in 
the Asia-Pacific region (86% Asian; 2 study populations were 
from Australia), the cutoff values were 85 cm for men and 80 
cm for women (7). This study showed that the prevalence of di-Kim HI, et al.  •  Diagnostic Values of Obesity-related Parameters for Predicting Metabolic Syndrome
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abetes was consistently higher among Asians than that of Euro-
peans at any given level of the BMI or WC. This clarifies the eth-
nic differences in the relationship between being overweight 
and having diabetes.
  WC measurement is a simple and widely applicable method 
to evaluate central obesity (8). However, it does not accurately 
reflect the abdominal visceral fat mass since it is also influenced 
by the amount of subcutaneous fat. The currently available meth-
ods that reliably measure the amount of abdominal visceral fat 
include computed tomography (CT) and magnetic resonance 
imaging (MRI). CT and MRI can distinguish fat from other tis-
sues and they allow measurement of the visceral and subcuta-
neous abdominal fat mass independently with high reproduc-
ibility (9, 10). Nevertheless, these methods are disadvantageous 
for routine use due to the radiation exposure, the technical dif-
ficulties and the high cost. In this regard, other methods of as-
sessing the amount of visceral fat such as ultrasonography and 
the abdominal sagittal diameter have been suggested (11, 12). 
New, alternative, simple and noninvasive methods that can ac-
curately reflect the visceral fat need to be developed. Therefore, 
we examined the diagnostic values and optimal cutoff points of 
various obesity-related parameters, including the CT-measured 
visceral fat area (VFA), to predict the risk of MetS in Korean men 
and women. In addition, we investigated whether these cutoff 
levels are useful in reflecting other markers of insulin resistance 
and atherosclerosis (e.g., the homeostasis model assessment for 
insulin resistance [HOMA-IR] and the mean carotid intima-me-
dia thickness [IMT]).
MATERIALS AND METHODS
Subjects
A total of 280 subjects (95 men and 185 women) aged 30-80 yr 
were recruited by local advertisement. The exclusion criteria 
consisted of the following: 1) an age < 30 or > 80 yr, 2) any indi-
viduals taking medications for hypertension, hyperglycemia, 
hyperlipidemia or obesity, and 3) pregnancy. The menopausal 
status in women was checked by self-report of the regularity of 
their menstrual cycle. 
Measurements
The height and body weight were measured to the nearest 0.1 cm 
and 0.1 kg, respectively, with the subjects standing barefoot and 
in light clothing. The BMI was calculated as the body weight in 
kilograms divided by the square of the height in meters. The WC 
was measured at the midpoint between the inferior border of the 
subcostal margin and iliac crest in the mid-axillary line after nor-
mal expiration with the subject standing; the hip girth was mea-
sured at the widest part of the hip across both greater trochan-
ters, from which the waist-to-hip circumference ratio (WHR) 
was calculated. Blood pressure was measured using a mercury 
sphygmomanometer in a sitting position after the participants 
had remained seated for 10 min. The measurements were taken 
twice, 5 min apart. 
  After an overnight 12 hr fast, the plasma glucose, total choles-
terol, triglyceride and high-density lipoprotein (HDL) cholester-
ol concentrations were measured enzymatically using an auto-
analyzer (ADVIA 1650; Siemens Medical Solutions Diagnostics, 
Tarrytown, NY, USA). The plasma insulin concentrations were 
measured by radioimmunoassay (BioSource S. A., Nivelles, Bel-
gium). The HOMA-IR was calculated using the following equa-
tion: HOMA-IR = (fasting insulin [μU/mL] × fasting glucose [mM/ 
L])/22.5 (13).
  A single CT scan (Sensation 16; Siemens AG, Forchheim, Ger-
many) at the level of the L4-5 vertebra was obtained with the 
patient in the supine position and at the end of inspiration. The 
cross-sectional area of fat was determined with attenuation val-
ues selected between the range of -250 and -50 Hounsfield units 
and using commercial software (Rapidia; Infinitt, Seoul, Korea). 
Carotid ultrasound studies were performed once for each sub-
ject by a single technician using a linear probe. The mean IMT 
of the common carotid artery was measured by an ultrasonog-
raphy apparatus (Logic 7; GE Medical Systems, Milwaukee, WI, 
USA) equipped with IMT measurement software (Intimascope; 
Media Cross Co., Tokyo, Japan) (14).
Definition of metabolic syndrome
MetS was defined according to the IDF criteria (5). The IDF has 
defined MetS as the presence of central obesity (WC ≥ 90 cm in 
men, WC ≥ 80 cm in women) plus two or more of the following 
criteria: 1) a systolic blood pressure (SBP) ≥ 130 mmHg and/or 
a diastolic blood pressure (DBP) ≥ 85 mmHg; 2) HDL cholesterol 
< 40 mg/dL in men, < 50 mg/dL in women; 3) triglyceride ≥ 150 
mg/dL and 4) the fasting plasma glucose ≥ 100 mg/dL. 
Statistical analyses
Statistical analyses were conducted using SPSS version 11.5 for 
Windows (SPSS Inc., Chicago, IL, USA). Continuous variables 
were expressed as means ± standard deviations (SD). Each vari-
able was examined for normality, and the skewed variables were 
tested after log-transformation. Continuous variables were com-
pared by Student’s t-test and the frequencies were compared by 
Pearson chi-squared test. The ROC curve analyses were per-
formed to determine the optimal cutoff points for the VFA, the 
WC, the BMI, the WHR, the subcutaneous fat area (SFA) and the 
visceral-to-subcutaneous fat area ratio (V/S) for identifying the 
subjects with two or more components of MetS other than the 
WC. Comparisons of the diagnostic values of the tests were per-
formed using the areas under the curves (AUC), and the signifi-
cance of the difference between the two areas was assessed by 
the method described by Hanley and McNeil (15). The values of 
various obesity-related indices that resulted in maximizing the Kim HI, et al.  •  Diagnostic Values of Obesity-related Parameters for Predicting Metabolic Syndrome
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Youden index (sensitivity + specificity - 1) were defined as opti-
mal (16). The WC and BMI values corresponding to each VFA cut-
off were calculated by simple linear regression analysis. P values 
< 0.05 (two-tailed) were considered to be statistically significant.
Ethics statement
The institutional review board of Seoul National University Hos-
pital approved the study protocol (H-0606/009-175). Informed 
consent was obtained from each subject.
RESULTS
Subject characteristics
The clinical characteristics of the study subjects are shown in 
Table 1. The prevalence of MetS according to the diagnostic cri-
teria of IDF was 28.4% in the men and 19.5% in the women. The 
proportion of subjects having central obesity, which is defined 
as a WC ≥ 90 cm in men and a WC ≥ 80 cm in women, was 42.1% 
in the men and 57.3% in the women. The proportion of subjects 
having higher blood pressure, which is defined as a SBP ≥ 130 
mmHg and/or a DBP ≥ 85 mmHg, was 29.5% in the men and 
12.4% in the women. Regarding the triglyceride levels, 36.8% of 
the men and 18.9% of the women had triglyceride levels ≥ 150 
mg/dL. A low HDL cholesterol level, which is defined as < 40 
mg/dL in men and < 50 mg/dL in women, was seen in 45.3% of 
the men and 58.9% of the women. The proportion of subjects 
having fasting hyperglycemia, which is defined as ≥ 100 mg/dL, 
was 31.6% in the men and 11.9% in the women. 
ROC curve analyses
Table 2 presents the AUC values, the statistical significance of the 
difference between the AUC value of each parameter and that of 
the VFA, the optimal cutoff points of six obesity-related indices 
for detecting two or more components of MetS other than WC, 
and the sensitivity and specificity of the cutoff point. The AUC of 
the VFA was comparable with that of the WC, BMI or SFA in men, 
whereas the VFA showed significantly higher AUC values than 
did the WC, BMI, WHR or SFA in women. The optimal cutoff 
points of the VFA, SFA, V/S, WC, BMI, and WHR were 136.0 cm
2, 
134.0 cm
2, 1.0, 89.0 cm, 24.1 kg/m
2, and 0.9 in men, and 95.0 cm
2, 
213.0 cm
2, 0.5, 85 cm, 24.0 kg/m
2, and 0.9 in women, respective-
ly. The sensitivity and specificity at the optimal cutoff points of 
the VFA were 74.3% and 78.3% in men and 79.1% and 77.4% in 
women, respectively, whereas those values at the optimal cutoff 
points of the WC were 69.8% and 70.6% in men and 51.0% and 
81.3% in women, respectively. Subgroup analyses according to 
the menopausal status in women showed that the AUC of the 
VFA was significantly higher than that of the WC, BMI, or WHR 
in premenopausal women, whereas it was comparable to that of 
the WC, BMI, or WHR in postmenopausal women. The optimal 
cutoff points of the VFA, WC, and BMI were 87.3 cm
2, 85.0 cm, 
and 25.2 kg/m
2 in the postmenopausal women and 81.7 cm
2, 81.0 
cm, and 23.1 kg/m
2 in the premenopausal women, respectively.       
Estimation of the WC and BMI corresponding to the VFA 
cutoff points
Fig. 1 shows the relationship of the WC and BMI with the VFA 
Table 1. Characteristics of the study subjects
Parameters Men (n = 95) Women (n = 185) P value*
Age (yr) 54.5 ± 8.7 53.0 ± 6.7 0.149
Body mass index (kg/m
2) 24.6 ± 2.9 24.2 ± 3.2 0.244
Waist circumference (cm) 88.1 ± 7.7 81.9 ± 8.1 < 0.001
Waist-to-hip circumference ratio    0.89 ± 0.05   0.85 ± 0.07 < 0.001
Visceral fat area (cm
2) 129 ± 59   91 ± 43 < 0.001
Subcutaneous fat area (cm
2) 125 ± 49 189 ± 67 < 0.001
Visceral-to-subcutaneous fat area ratio 1.01 (0.73, 1.35) 0.47 (0.33, 0.61) < 0.001
Systolic blood pressure (mmHg) 117.2 ± 17.1 108.8 ± 13.4 < 0.001
Diastolic blood pressure (mmHg)   73.8 ± 12.8   70.4 ± 10.6 0.031
Fasting plasma glucose (mg/dL) 100.9 ± 28.8   90.9 ± 12.7 0.001
HOMA-IR 1.35 (0.86, 1.91) 1.15 (0.88, 1.68) 0.467
Total cholesterol (mg/dL) 187.6 ± 31.3 193.8 ± 32.4 0.134
Triglyceride (mg/dL) 118.6 (79.6, 193.8) 90.3 (66.4, 138.1) 0.001
HDL cholesterol (mg/dL)   41.3 ± 10.8   47.5 ± 10.4 < 0.001
Mean intima-media thickness (mm)   0.73 ± 0.13   0.70 ± 0.12 0.030
Metabolic syndrome (%) 28.4 19.5 0.089
Greater waist circumference (%) 42.1 57.3 0.016
High blood pressure (%) 29.5 12.4 < 0.001
Elevated triglyceride levels (%) 36.8 18.9 0.001
Lower HDL cholesterol (%) 45.3 58.9 0.030
Higher fasting plasma glucose (%) 31.6 11.9 < 0.001
The data is shown as means ± SD. or the median (interquartile range). *P values: by Student’s t-test for the continuous variables and by Pearson’s chi-square test for frequen-
cies. HOMA-IR, homeostasis model assessment for insulin resistance; HDL, high-density lipoprotein.Kim HI, et al.  •  Diagnostic Values of Obesity-related Parameters for Predicting Metabolic Syndrome
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Table 2. Areas under the ROC curve for the obesity-related parameters as well as the sensitivity and specificity at the optimal cutoff point for detecting two or more compo-
nents of metabolic syndrome other than waist circumference 
Parameters ROC curve area (95% CI) P value Compared with VFA* Cutoff point Sensitivity (%) Specificity (%)
Men (n = 95)
   VFA
   WC 
   BMI 
   WHR
   V/S
   SFA 
 
0.78 (0.67-0.88)
0.75 (0.64-0.86)
0.71 (0.60-0.83)
0.64 (0.52-0.76)
0.66 (0.54-0.78)
0.67 (0.56-0.79)
 
 
0.579
0.282
0.008
0.043
0.110
 
136.0 cm
2
 89.0 cm
24.1 kg/m
2 
0.9
1.0
134.0 cm
2 
 
74.3
69.8
74.3
82.9
68.6
51.4
 
78.3
70.6
60.0
55.6
64.4
77.8
Women (n = 185)
   VFA
   WC 
   BMI 
   WHR
   V/S
   SFA 
 
0.78 (0.70-0.86)
0.64 (0.54-0.74)
0.66 (0.56-0.75)
0.66 (0.55-0.76)
0.74 (0.66-0.83)
0.57 (0.46-0.67)
 
 
< 0.001
0.005
0.012
0.370
< 0.001
 
  95.0 cm
2
 85.0 cm
24.0 kg/m
2
0.9
0.5
213.0 cm
2
 
79.1
51.0
61.2
65.3
69.8
41.9
 
77.4
81.3
67.9
70.9
72.6
79.8
Premenopausal Women (n = 94)
   VFA
   WC 
   BMI 
   WHR
   V/S
   SFA 
 
0.76 (0.65-0.85)
0.52 (0.41-0.63)
0.60 (0.49-0.70)
0.55 (0.44-0.66)
0.81 (0.71-0.88)
0.60 (0.49-0.70)
 
 
< 0.001
0.035
0.008
0.503
0.063
 
  81.7 cm
2
 81.0 cm
23.1 kg/m
2 
0.9
0.5
167.1 cm
2 
 
78.6
58.8
76.5
58.8
78.6
71.4
 
77.5
67.1
52.6
69.7
81.7
54.9
Postmenopausal Women (n = 80)
   VFA
   WC 
   BMI 
   WHR
   V/S
   SFA 
 
0.76 (0.64-0.85)
0.69 (0.58-0.80)
0.71 (0.60-0.81)
0.68 (0.56-0.78)
0.62 (0.50-0.73)
0.68 (0.56-0.78)
 
 
0.322
0.504
0.299
0.053
0.267
 
 87.3 cm
2
 85.0 cm
25.2 kg/m
2
0.9
0.4
213.0 cm
2
 
92.0
59.3
63.0
66.7
96.0
60.0
 
59.2
79.2
77.4
69.8
34.7
73.5
*P value compared with the visceral fat area by the method of Hanley and McNeil (19). ROC, receiver operating characteristic; VFA, visceral fat area; WC, waist circumference; 
BMI, body mass index; WHR, waist-to-hip circumference ratio; V/S, visceral-to-subcutaneous fat area ratio; SFA, subcutaneous fat area ratio.
V
F
A
 
(
c
m
2
)
V
F
A
 
(
c
m
2
)
V
F
A
 
(
c
m
2
)
V
F
A
 
(
c
m
2
)
Waist circumference (cm) Waist circumference (cm)
BMI (kg/m
2) BMI (kg/m
2)
Men Women
r = 0.733 r = 0.652
r = 0.612 r = 0.608
136 cm
2
95 cm
2
136 cm
2
95 cm
2
89 cm 82 cm
25.2 kg/m
2 24.5 kg/m
2
60  70  80  90  100  110  120 60  70  80  90  100  110
16  18  20  22  24  26  28  30  32  34  36 16  18  20  22  24  26  28  30  32  34  36
280
260
240
220
200
180
160
140
120
100
80
60
40
20
0
240
220
200
180
160
140
120
100
80
60
40
20
0
280
260
240
220
200
180
160
140
120
100
80
60
40
20
0
240
220
200
180
160
140
120
100
80
60
40
20
0 Fig. 1. Body mass index and waist circum-
ference corresponding to the visceral fat 
area (VFA) cutoff values for men and women.Kim HI, et al.  •  Diagnostic Values of Obesity-related Parameters for Predicting Metabolic Syndrome
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for the men and women. The WC and BMI values correspond-
ing to the optimal cutoff points of the VFA were estimated by a 
simple linear regression equation. There was a significant corre-
lation between the VFA and WC (r = 0.733, P < 0.001 for the men 
and r = 0.652, P < 0.001 for the women) and between the VFA and 
BMI (r = 0.612, P < 0.001 for the men and r = 0.608, P < 0.001 for 
the women). The WC corresponding to the VFA cutoff was 89 cm 
for the men and 82 cm for the women. The BMI corresponding 
to the VFA cutoff was 25.2 kg/m
2 for the men and 24.5 kg/m
2 for 
the women. Subgroup analyses according to the menopausal 
status in women showed that the VFA appeared to have better 
correlation with the WC and BMI in the postmenopausal women 
compared to that of the premenopausal women (r = 0.650, P < 
0.001 and r = 0.630, P < 0.001 for the postmenopausal women 
and r = 0.581, P < 0.001 and r = 0.535, P < 0.001 for the premeno-
pausal women). The WC and BMI corresponding to the VFA cut-
off were 81 cm and 23.8 kg/m
2 for the premenopausal women 
and 81 cm and 23.7 kg/m
2 for the postmenopausal women, re-
spectively (Fig. 2). 
Mean IMT and HOMA-IR according to the VFA and WC cutoffs
Fig. 3 shows the mean IMT and HOMA-IR according to the cut-
off points of the VFA (136 cm
2 for the men and 95 cm
2 for the 
women) and WC (89 cm for the men and 82 cm for the women). 
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Fig. 2. Body mass index and waist circum-
ference corresponding to the visceral fat 
area (VFA) cutoff values for pre- and post-
menopausal women. 
The subjects who had a WC above the cutoff points exhibited 
higher values of the IMT (0.76 mm vs 0.70 mm, P = 0.021 for the 
men and 0.73 mm vs 0.67 mm, P = 0.001 for the women) and an 
elevated HOMA-IR (2.23 vs 1.18, P = 0.001 for the men and 1.57 
vs 1.28, P = 0.024 for the women) as compared to their counter-
parts. Although the VFA displayed a similar trend with the WC, 
the IMT in men and the HOMA-IR in women were marginally 
higher for the subjects with a VFA above the cutoff points than 
those values for the subjects with a VFA below the cutoff points 
(0.76 mm vs 0.71 mm, P = 0.08 for the men and 1.56 vs 1.32, P = 
0.069 for the women).
Prevalence of MetS according to the VFA and WC cutoffs
Fig. 4. shows the prevalence of MetS in the 4 groups that were 
subdivided by the VFA and WC cutoffs: 1) a lower VFA and a 
lower WC (a VFA below the cutoff and a WC below the cutoff), 
2) a lower VFA and a higher WC (a VFA below the cutoff and a 
WC above the cutoff), 3) a higher VFA and a lower WC (a VFA 
above the cutoff and a WC below the cutoff), and 4) a higher VFA 
and a higher WC (a VFA above the cutoff and a WC above the 
cutoff) group. For the men, a WC cutoff value was associated 
with the prevalence of MetS among the subjects who had a VFA 
below the cutoff point (50.0% in the lower VFA and higher WC 
group vs 13.9% in the lower VFA and lower WC group, P = 0.042), Kim HI, et al.  •  Diagnostic Values of Obesity-related Parameters for Predicting Metabolic Syndrome
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but not among subjects who had a VFA above the cutoff point 
(72.4% in the higher VFA and higher WC group vs 71.4% in the 
higher VFA and lower WC group, P = 0.645). By contrast, for the 
women, the WC cutoff value was not associated with the preva-
lence of MetS among the subjects who had a VFA below the cut-
off point (10.7% in the lower VFA and lower WC group vs 3.4% 
in the lower VFA and higher WC group, P = 0.224) and among 
subjects who had a VFA above the cutoff point (54.3% in the 
higher VFA and higher WC group vs 53.3% in the higher VFA 
and lower WC group, P = 0.589).
DISCUSSION
Our results demonstrated that the cutoff points of the VFA, which 
are 136 cm
2 for men and 95 cm
2 for women, are optimal for yield-
ing the maximal sensitivity plus specificity for predicting two or 
more components of MetS other than the WC. To date, a few 
previous studies have determined the optimal cutoff points of 
the VFA for MetS in the Korean population. Han et al. (17) ana-
lyzed the data from a hospital-based sample of 276 Korean men 
(age: 45.5 ± 9.4 yr, BMI: 25.4 ± 2.5 kg/m
2) and 540 Korean women 
(age: 40.7 ± 12.2 yr, BMI: 25.4 ± 2.7 kg/m
2). They suggested 100 
cm
2 in men and 70 cm
2 in women as the optimal cutoff points 
for identifying subjects with multiple risk factors of MetS as de-
fined by the IDF criteria (17). In another Korean study, the VFA 
cutoff level was proposed to be 103.8 cm
2 for both men (age: 41.3 
± 11.6 yr, BMI: 30.9 ± 5.2 kg/m
2) and women (age: 43.2 ± 13.1 yr, 
BMI: 29.9 ± 5.7 kg/m
2) (18). In 1,870 Japanese subjects (the mean 
age and BMI were 50.6 ± 7.8 yr and 24.9 ± 2.7 kg/m
2 in men and 
51.2 ± 7.2 yr and 23.5 ± 3.1 kg/m
2 in women, respectively), the 
cutoff points of the VFA and WC for identifying subjects with at 
least two non-adipose components of MetS were 132.6 cm
2 and 
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89.8 cm in men and 91.5 cm
2 and 82.3 cm in women, respective-
ly (19), which are quite similar to our results. They also showed 
that the VFA is a better parameter than the WC or BMI for detect-
ing multiple metabolic risk factors (19). The results from these 
studies and ours suggest that the VFA cutoff levels for identify-
ing subjects with multiple metabolic risk factors are influenced 
by the age and the BMI distribution of the study populations. 
  Previous studies have reported that insulin resistance is more 
strongly associated with the VFA rather than with the WHR or 
the WC (20). As the WC reflects not only visceral fat but also sub-
cutaneous fat, it does not appear to be a good indicator of the 
VFA (21). Intriguingly, our current study displayed a gender dif-
ference in the diagnostic values of the VFA and other obesity-
related anthropometric parameters for predicting non-adipose 
components of MetS. Subgroup analyses showed that for the 
men, the WC cutoff value was associated with the prevalence of 
MetS among the subjects who had a VFA below the cutoff point. 
However, only the VFA cutoff value, and not WC cutoff value, was 
associated with the prevalence of MetS in women (Fig. 4). In ad-
dition, although the AUC of the WC was comparable to that of 
the VFA in men, the WC exhibited a significantly lower AUC than 
the VFA in women, and more precisely in the premenopausal 
women, which indicates that the WC has limited value for pre-
dicting MetS in premenopausal women. In our study, the pre-
menopausal women displayed a significantly lower V/S than did 
the postmenopausal women (0.43 vs 0.54, respectively, P < 0.001). 
Therefore, it can be concluded that the WC is more influenced 
by subcutaneous fat than by visceral fat in premenopausal wom-
en. In accordance with our finding, a recent study has demon-
strated that the VFA rather than the WC itself is a major determi-
nant of MetS in premenopausal Korean women (22), whereas 
the WC and VFA are similarly useful in identifying MetS in elder-
ly Korean women (23). Since the body fat distribution is deter-
mined by several factors, including age, gender, and the meno-
pausal status (24), different methods and cutoff values for pre-
dicting MetS may be necessary even in a single ethnic group. 
Especially, in premenopausal women, the directly measured 
VFA or a simple clinical measurement reflecting the VFA would 
be indispensable for predicting MetS. 
  We found significant differences in the mean IMT and HOMA-
IR between the subgroups, as were divided by the WC cutoff 
point of 89 cm in men and 82 cm in women (Fig. 3). The HOMA-
IR is an indicator of insulin resistance, and the IMT of the com-
mon carotid artery is an indicator of atherosclerosis and they 
have both proposed as independent predictors of cardiovascu-
lar disease (25, 26). In line with our results, the WC has been as-
sociated with surrogate measures of insulin resistance and ath-
erosclerosis and with their progression in several population-
based cross-sectional and longitudinal studies (27-29). There-
fore, the WC cutoff values presented in this study may be useful 
for predicting insulin resistance and subclinical atherosclerosis, 
although they are slightly inferior to the VFA for identifying sub-
jects with multiple non-adipose components of MetS.
  In summary, this study demonstrates that the diagnostic val-
ues of the VFA and WC for predicting the presence of multiple 
metabolic risk factors are influenced by gender and the meno-
pausal status. The optimal cutoff points of the VFA and WC for 
reflecting multiple non-adipose components of MetS were 136 
cm
2 and 89 cm in men and 95 cm
2 and 82 cm in women, respec-
tively. Further, these cutoff values may indicate an increased 
HOMA-IR and IMT. Although the WC and VFA are useful to a 
similar extent in men and postmenopausal women, the WC is 
inferior to the VFA in premenopausal women. It is mandatory 
to develop a simple clinical parameter that reflects visceral fat 
in premenopausal women. 
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Receiver operating characteristic (ROC) curve analysis revealed that the optimal cutoff points of visceral fat area and waist 
circumference for predicting metabolic syndrome in Korean population were 136 cm
2 and 89 cm in men and 95 cm
2 and 82 cm in 
women, respectively. The subjects with visceral fat area and waist circumference above these cutoff values exhibited increased insulin 
resistance and an increased carotid intima-media thickness. Diagnostic values of the obesity-related parameters for predicting 
metabolic syndrome are influenced by gender and the menopausal status. The waist circumference and visceral fat area exhibited 
similar diagnostic values for men and postmenopausal women, whereas waist circumference was inferior to visceral fat area for 
premenopausal women. Therefore, a simple clinical parameter that reflects visceral fat in premenopausal women needs to be developed.